More tools:Markets·Screener·Research·Chat

Abeona Therapeutics Inc. Common Stock (ABEO) Financial Statements

Abeona Therapeutics Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001S8T7K0
XNAS · usd
5.89▲ 0.04 (0.68%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close5.85
Day's Range5.81 – 6.00
52-Week Range4.00 – 7.65
Volume842.0K
Avg Volume1.4M
Share Statistics
Shares Outstanding
Employees226
ExchangeXNAS
Listed1980-09-19
Share count as of August 10, 2026
Loading Income Statement…
Key questions about Abeona Therapeutics Inc. Common Stock (ABEO)
What is Abeona Therapeutics Inc. Common Stock's Market Cap?
Abeona Therapeutics Inc. Common Stock's Market Cap is $336.8M, based on as-reported figures from SEC (XBRL) filings.
What is Abeona Therapeutics Inc. Common Stock's Enterprise Value?
Abeona Therapeutics Inc. Common Stock's Enterprise Value is $205.0M, based on as-reported figures from SEC (XBRL) filings.
What is Abeona Therapeutics Inc. Common Stock's Price / Sales?
Abeona Therapeutics Inc. Common Stock's Price / Sales is 13.2×, based on as-reported figures from SEC (XBRL) filings.
What is Abeona Therapeutics Inc. Common Stock's EV / Revenue?
Abeona Therapeutics Inc. Common Stock's EV / Revenue is 8.0×, based on as-reported figures from SEC (XBRL) filings.
What is Abeona Therapeutics Inc. Common Stock's EV / EBITDA?
Abeona Therapeutics Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Abeona Therapeutics Inc. Common Stock's Revenue (TTM)?
Abeona Therapeutics Inc. Common Stock's Revenue (TTM) is $25.5M, based on as-reported figures from SEC (XBRL) filings.
What is Abeona Therapeutics Inc. Common Stock's Net Income (TTM)?
Abeona Therapeutics Inc. Common Stock's Net Income (TTM) is -$62.9M, based on as-reported figures from SEC (XBRL) filings.
What is Abeona Therapeutics Inc. Common Stock's EBITDA?
Abeona Therapeutics Inc. Common Stock's EBITDA is -$80.8M, based on as-reported figures from SEC (XBRL) filings.
What is Abeona Therapeutics Inc. Common Stock's Diluted EPS (TTM)?
Abeona Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -1.10, based on as-reported figures from SEC (XBRL) filings.
What is Abeona Therapeutics Inc. Common Stock's EBITDA Margin?
Abeona Therapeutics Inc. Common Stock's EBITDA Margin is -316.6%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues:
Revenue
YoY growth+2745.0%———
Costs and expenses:
Cost of Revenue
Other Operating Expense——
Research and Development Expense
Selling, General and Administrative Expense
Total costs and expenses
% of revenue220.0%364.1%522.7%—
Loss from operations
% of revenue-120.0%-264.1%-422.7%—
Total Interest Income
Interest expense
Change in fair value of warrant liabilities
Gain from sale of priority review voucher, net——
Non-Operating Income (Expense)
(Loss) income before income taxes
Income Tax Expense
Net (loss) income
% of revenue-177.4%-195.8%-377.5%—
Earnings Per Share (Basic)
Earnings Per Share (Diluted)—
Other comprehensive (loss) income:
Change in unrealized losses related to available-for-sale debt securities
Comprehensive (loss) income